National Public Radio on Monday ran a so-called sponsor message promoting pharma giant Procter & Gamble’s nerve relief drug Nervive, "designed to reduce occasional nerve aches, weakness and discomfort." The message, effectively a commercial, is tied to one of hundreds of advertiser deals that are far more important to NPR than government funding. NPR brought in $100 million from corporate sponsors in 2023, compared to only $7 million in federal funding.
The post Has Brendan Carr Finally Figured Out How To Stop NPR? appeared first on .